-
Small Molecule Drug Discovery Market Size, Share, Competitive Landscape and Trend Analysis Report
25 Nov 2025 00:15 GMT
…
• AstraZeneca
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Johnson & Johnson
• Gilead … data insights into decisions.
Market Share And Forecast By Segment In …
-
Diffuse Large B-cell Lymphoma Therapeutics Market - Opportunities, Share, and Competitive Analysis and Forecast 2029
24 Nov 2025 09:30 GMT
The Business Research Company's Diffuse Large B-cell Lymphoma Therapeutics Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, November 24, 2025 /EINPresswire.com/ -- What Is …
-
DNA Repair Drugs Market Size, Share & Trends Analysis Report By Product
24 Nov 2025 09:30 GMT
The Business Research Company's DNA Repair Drugs Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, November 24, 2025 /EINPresswire.com/ -- What Is The DNA Repair Drugs …
-
Small Molecule Drug Discovery Market Size, Share, Competitive Landscape and Trend Analysis Report
24 Nov 2025 00:15 GMT
…
• AstraZeneca
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Johnson & Johnson
• Gilead … data insights into decisions.
Market Share And Forecast By Segment In …
-
Comprehensive Report on the Melanoma Drugs Market: Opportunities and Challenges
25 Nov 2025 06:35 GMT
… Melanoma Drugs include:
• Amgen Inc.
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche … agency within the United States. Bristol-Myers Squibb Company, a pharmaceutical firm based … Region Holds The Largest Market Share In The Melanoma Drugs Market …
-
Systemic Lupus Erythematosus Treatment Market Size to Reach $5.07 Bn by 2029 – Report by The Business Research Company
25 Nov 2025 06:35 GMT
… & Co Inc.
• AstraZeneca plc
• Bristol-Myers Squibb Company Inc.
• F. Hoffmann-La … Systemic Lupus Erythematosus Treatment Market Share?
The systemic lupus erythematosus treatment …
-
Angiotensin Receptor Blockers (ARBs) Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
21 Nov 2025 10:00 GMT
… & Co. Inc.
• AstraZeneca Plc.
• Bristol-Myers Squibb Company
• GlaxoSmithKline plc
• Teva Pharmaceutical … America held the dominant market share for angiotensin receptor blockers (ARBs …
-
Enzyme Inhibitor Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
21 Nov 2025 05:22 GMT
The Business Research Company's Enzyme Inhibitor Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034
LONDON, GREATER LONDON, UNITED KINGDOM, November 21, 2025 /EINPresswire.com/ -- "Get 20% Off All Global …
-
Myeloproliferative Disorders Drugs Market is Forecasted to Reach a Value of US $11.51 Billion by 2029
25 Nov 2025 00:00 GMT
… Disorders Drugs include:
• Novartis AG
• Bristol-Myers Squibb Company
• Pfizer Inc.
• Takeda Pharmaceutical … Region Holds The Largest Market Share In The Myeloproliferative Disorders Drugs …
-
Trading on Whispers Alone
24 Nov 2025 23:38 GMT
… forecast last week, and shares ticked up in early trading … for a cardiovascular drug. Bristol-Myers Squibb rose in sympathy, as … interest and boosting its shares by 4.7%.
Revolut … billion following a secondary share sale involving major investors like …
About
© 1995-2025